| Name | Title | Contact Details |
|---|
Bicara Therapeutics is a clinical-stage company developing first-in-class biologics engineered to bring together the precision of targeted therapy and the power of tumor modulators. The company`s dual-action biologics are designed to deliver an immunomodulatory payload directly to the tumor microenvironment to ramp up immune cell activity, potentially offering long-lasting efficacy.
Phagetech is a Saint-Laurent, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Deltanoid Pharmaceuticals is a Madison, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Adherium (ASX.ADR) is a global leader in digital health technologies which address sub-optimal medication use in chronic disease.
Sandoz, a Division of the Novartis group, is a global leader in the field of generic pharmaceuticals, offering a wide array of high-quality, affordable products that are no longer protected by patents.